Tenax Therapeutics (TENX) Retained Earnings (2016 - 2017)
Historic Retained Earnings for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to -$212.2 million.
- Tenax Therapeutics' Retained Earnings fell 2122.33% to -$212.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$212.2 million, marking a year-over-year decrease of 2122.33%. This contributed to the annual value of -$204.7 million for FY2016, which is N/A changed from last year.
- Tenax Therapeutics' Retained Earnings amounted to -$212.2 million in Q3 2017, which was down 2122.33% from -$210.9 million recorded in Q2 2017.
- Over the past 5 years, Tenax Therapeutics' Retained Earnings peaked at -$115.2 million during Q1 2013, and registered a low of -$212.2 million during Q3 2017.
- Moreover, its 4-year median value for Retained Earnings was -$175.0 million (2016), whereas its average is -$174.9 million.
- Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 874.84% in 2013, then plummeted by 2732.68% in 2016.
- Tenax Therapeutics' Retained Earnings (Quarter) stood at -$117.0 million in 2013, then plummeted by 37.33% to -$160.7 million in 2015, then dropped by 27.33% to -$204.7 million in 2016, then dropped by 3.66% to -$212.2 million in 2017.
- Its last three reported values are -$212.2 million in Q3 2017, -$210.9 million for Q2 2017, and -$207.9 million during Q1 2017.